| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |